Fabulous! Don't forget to share with your friends on Twitter and Facebook.

Horizon Pharma: Rayos FDA Approval Thursday Seems Likely

Perhaps the biggest risk to Horizon going into tomorrow’s FDA approval decision is the stock’s run from $4 to $7.50 over the past six weeks. That’s a big move ahead of a major catalyst and can often lead to a significant sell off once Rayos’ approva…